AI assistant
Cipla Ltd. — Interim / Quarterly Report 2019
Dec 3, 2019
59275_rns_2019-12-03_15fe8aa7-ddc7-4dd2-89db-64afa21c4c0e.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer

3rd December, 2019
- (1) BSE Ltd Listing Department Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001
- (2) National Stock Exchange of India Ltd Listing Department Exchange Plaza, 51 h floor, Plot no. C/1, G Block, Sandra Kurla Complex, Sandra (East), Mumbai - 400 051
Scrip Code: 500087
Scrip Code: CIPLA
(3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg
Sub: Disclosure of related party transactions for the half year ended 30th September, 2019
Dear Sir/Madam,
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended 3Q1 hSeptember, 2019.
This disclosure is also being uploaded on the website of the Company i.e. www.cipla.com.
This is for your information and record.
Thanking you,
Rajendra Chopra Company Secretary
Prepared by: Pratiksha Mangaonkar
Ud.

Information on related party transactions as required by lnd AS-24 - 'Related Party Disclosures' are given below: list of related parties A. Associate Stempeutics Research Private Limited Avenue Therapeutics Inc. Brandmed (Pty} Ltd. (w.c.f. 24th April, 2019}
B. Key Management Personnel
Ms. Sam ina Vaziralli- Executive Vice-Chairperson Mr. Umang Vohra- Managing Director and Global Chief Executive Officer Mr. Kedar Upadhye- Global Chief Financial Officer Dr. Raghunath an Ananthanarayanan- President and Global Chief Operating Officer
C. Non-Executive Chairman & Non-Executive Vice Chairman
Dr. Y.K. Hamied, Chairman Mr. M.K. Hamied, Vice Chairman
D. Non Executive Directors
Mr. Ashok Sinha Mr. Adil Zainulbhai Ms. Punita Lal Ms. Naina Lal Kidwai Mr. Peter Lankau (upto 30th June, 2019} Dr. Peter Mugyenyi Mr. S Radhakrishnan
E. Entities over which Key Management Personnel are able to exercise significant influence Cipla Foundation
Chest Research Foundation (formerly known as Hamied Foundation upto 14th October, 2019} Cipla Cancer and AIDS Foundation
F. Trust over which entity has control/significant influence
Cipla Limited Employees Provident Fund Cipla Limited Employees Gratuity Fund Cipla Employees Stock Option Trust Cipla Health Employees Stock Option Trust

Cipla Ud.
| ~in Crores | |
|---|---|
| Particulars | For the half year ended |
| th 30 September, 2019 | |
| Remuneration (Including sitting fees)*A. | |
| Dr. Y.K. Hamied | 1.01 |
| Mr. M.K. Hamied | 1.04 |
| Ms. Samina Vaziralli | 3.36 |
| Mr. Umang Vohra | 7.23 |
| Mr. S Radhakrishnan | 1.06 |
| Mr. Kedar Upadhye | 1.93 |
| Mr. Ashok Sinha | 0.24 |
| Mr. Adil Zainulbhai | 0.23 |
| Ms. Punita Lal | 0.21 |
| Ms. Naina Lal Kidwai | 0.23 |
| Mr. Peter Lankau | 0.17 |
| Dr. Peter Mugyenyi | 0.40 |
| Dr. Raghunathan Ananthanarayanan | 6.22 |
| 23.33 |
* Expenses towards gratuity and leave encashment prov1s1ons are determined actuarially on an overall company basis at the end of each year and accordingly have not been considered in the above information
| Testing and analysis charges paidB. | |
|---|---|
| Stempeutics Research Private Limited | 0.98 |
| 0.98 | |
| Contribution to provident fund and other fundC. | |
| Cipla Limited Employees Provident Fund | 20.91 |
| 20.91 | |
| Donations givenD. | |
| Cipla Foundation | 18.42 |
| 18.42 | |
| Rent receivedE. | |
| Dr. Y.K. Hamied (Rs. 10,020/-) | 0.00 |
| 0.00 | |
| Reimbursement of operating/other expensesF. | |
| Stempeutics Research Private Limited | 0.04 |
| 0.04 | |
| Investment made during the periodG. | |
| Brandmed (Pty) Ltd. | 31.61 |
| 31.61 |

ltd.
Regd. Office- Ciplo House, Peninsula Business Park, Ganpatroo Kadom Marg, Lower Parel, Murnbai ~00013, India. p •'II 22 21,826000 F •91 22 21,826120 W www.cipla.corn E-Mail [email protected] Corporate Identity Number L24239MHI'I35PLC002380
| ~in Crores | |
|---|---|
| For the half year ended | |
| Particulars | th 30 September, 2019 |
| Payable to Key Management PersonnelH. | |
| Dr. Y.K. Hamied | 1.00 |
| Mr. M.K. Hamied | 1.00 |
| Ms. Samina Vaziralli | 1.15 |
| Mr. Umang Vohra | 2.00 |
| Mr. 5 Radhakrishnan | 1.00 |
| Mr. Kedar Upadhye | 0.48 |
| Mr. Ashok Sinha | 0.20 |
| Mr. Adil Zainulbhai | 0.18 |
| Ms. Punita Lal | 0.18 |
| Ms. Naina Lal Kidwai | 0.18 |
| Mr. Peter Lankau | 0.10 |
| Dr. Peter Mugyenyi | 0.21 |
| Dr. Raghunathan Ananthanarayanan | 1.38 |
| 9.06 | |
| Contribution payable to provident fundI. | |
| Cipla Limited Employees Provident Fund | 3.45 |
| 3.45 | |
| Payable to gratuity fundJ. | |
| Cipla Limited Employees Gratuity Fund | 21.63 |
| 21.63 | |
| Dividend PaidK. | |
| Dr. Y.K. Hamied | 49.19 |
| Mr. M.K. Hamied | 10.37 |
| Ms. Samina Vaziralli | 5.37 |
| Mr. Umang Vohra | 0.06 |
| Mr. 5 Radhakrishnan | 0.03 |
| Mr. Kedar Upadhye | 0.01 |
| 65.03 |

Cipla Ud.
Regd. Oftice- Cipla Hause, Peninsula Business Park, Ganpatraa Kadam Marg, Lower Porel, lvfurnbai 00013, India. p •91 22 21,826000 F •91 22 21,826120 W www ciplo com E-N ail [email protected] Corporate Identity Number L2239MH1935PLC002380